Next Article in Journal
Carbon Nanotube/Alumina/Polyethersulfone Hybrid Hollow Fiber Membranes with Enhanced Mechanical and Anti-Fouling Properties
Previous Article in Journal / Special Issue
Impact of Carbon Nano-Onions on Hydra vulgaris as a Model Organism for Nanoecotoxicology
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nanomaterials
Volume 5
Issue 3
10.3390/nano5031351
nanomaterials-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Role of Physicochemical Properties in Nanoparticle Toxicity

by
Seung Won Shin
1,
In Hyun Song
1 and
Soong Ho Um
1,2,*
1
School of Chemical Engineering, Sungkyunkwan University, Suwon, Gyeonggi-do 440-746, Korea
2
SKKU Advanced Institute of Nanotechnology (SAINT), Sungkyunkwan University, Suwon, Gyeonggi-do 440-746, Korea
*
Author to whom correspondence should be addressed.
Nanomaterials 2015, 5(3), 1351-1365; https://doi.org/10.3390/nano5031351
Submission received: 11 May 2015 / Revised: 11 August 2015 / Accepted: 12 August 2015 / Published: 19 August 2015
(This article belongs to the Special Issue Advancements in Nanotoxicology)
Browse Figures
Versions Notes

Abstract

:
With the recent rapid growth of technological comprehension in nanoscience, researchers have aimed to adapt this knowledge to various research fields within engineering and applied science. Dramatic advances in nanomaterials marked a new epoch in biomedical engineering with the expectation that they would have huge contributions to healthcare. However, several questions regarding their safety and toxicity have arisen due to numerous novel properties. Here, recent studies of nanomaterial toxicology will be reviewed from several physiochemical perspectives. A variety of physiochemical properties such as size distribution, electrostatics, surface area, general morphology and aggregation may significantly affect physiological interactions between nanomaterials and target biological areas. Accordingly, it is very important to finely tune these properties in order to safely fulfill a bio-user’s purpose.

1. Introduction

Since basic concepts of nanotechnology were introduced in the mid-twentieth century by Richard Feynman, Norio Taniguchi and Eric Drexler, a large body of literature on nanomaterials has accumulated and has expanded significantly in the twenty first century (Figure 1 and Table 1). Furthermore, the rapid development of methods and tools for nanomaterial/colloid characterization has resulted in substantial advances in materials (i.e., fullerene and carbon nanotubes) [1]. Inspired by these trends, many scientists now favor nanomaterials with new characteristics over outdated bulky materials. As of the early 2000s, these newer materials have begun to deepen their impact on our daily lives in applications such as clothing, cosmetics, furniture, and even foods.
Nanomaterials 05 01351 g001 1024
Figure 1. The number of nanoscience papers indexed in Scopus between 2000 and 2014. Source: “Nanoparticle”, data from Scopus.
Figure 1. The number of nanoscience papers indexed in Scopus between 2000 and 2014. Source: “Nanoparticle”, data from Scopus.
Nanomaterials 05 01351 g001
Table
Table 1. Detail information about the graph was described in the table. Highly cited authors, country, and subject area are used as specific subsection of papers. Source: “Nanoparticle”, data from Scopus.
Table 1. Detail information about the graph was described in the table. Highly cited authors, country, and subject area are used as specific subsection of papers. Source: “Nanoparticle”, data from Scopus.
AuthorPapersCountryPapersSubject areaPapers
Couvreur, P.250United States39,702Chemistry62,277
Mirkin, C.A.244China31,406Materials Science59,895
Rotello, V.M.227India10,590Physics and Astronomy40,126
Muller, R.H.199Germany10,180Chemical Engineering40,108
Kreuter, J.186Japan9,951Engineering36,940
Weissleder, R.185South Korea9,118Biochemistry30,209
Genetics and Molecular Biology
Yuan, R.170United Kingdom6,809Medicine21,275
Xia, Y.149France6,484Pharmacology18,456
Toxicology and Pharmaceutics
Lanza, G.M.148Italy4,457Environmental Science8,709
Wickline, S.A.146Spain4,306Others21,726
The nanomaterials market has exploded. For example, titanium dioxide (TiO2) nanoparticles, which are a major ingredient in sunblock, absorb ultraviolet (UV) light and efficiently protect skin from harmful UV light exposure. They are also used in many cosmetics. In addition, silica dioxide (SiO2) is often used as a food additive to decrease viscosity and regulate acidity. Owing to their powerful anti-microbial and light-weight characteristics, silver (Ag) nanoparticles and carbon nanotubes (CNTs) are used extensively in a variety of cleansers and in sporting equipment. However, its safety is continuously debated among many scientists and clinicians.
The cytotoxicity of nanoparticles is induced by several factors. Some cases of nanomaterials inducing cytotoxicity are because of the substance itself, and some nanoparticles show toxicity without clear mechanism [2,3]. Some nanoparticles of a particular substance are thought to pose greater risks of toxicity than larger-sized particles of the same substance [4,5,6]. Above all, the distribution of particles within the body and the accumulation of a specific type of particle in a particular part of the body, which is dependent on the particle’s size and surface characteristic, are considered critical issues [7]. Also, when the nanoparticles accumulate in body system without proper excretion, it can cause continuous toxicity. The main distribution sites and target organs for nanoparticles are unknown; however it appears that the liver and spleen may be target organs [8,9]. If nanoparticles are ingested, inhaled or absorbed through the skin, they can induce the formation of reactive oxygen species (ROS) including free radicals [10]. ROS produces oxidative stress, inflammation, and consequent damage to various biological materials such as protein, DNA, etc. Besides ROS production, other factors influencing toxicity include size, morphology, agglomeration statue, shape, chemical composition, surface structure, surface charge, aggregation and solubility [11]. As a result of their small size, nanoparticles can cross tissue junctions and even cellular membranes where they induce structural damage to the mitochondria [12,13] or invade the nucleus where they cause serious DNA mutations [14] leading to cell death [15]. The factors mentioned above can be categorized under the five characteristics of nanoparticle, which are: size; surface area; electrostatic statue of surface; morphology; and agglomeration status.
Researchers have made a substantial effort to minimize unwanted interactions between nanomaterials and biological tissues. Researchers have investigated surface coatings and other modifications to increase the safety of nanoparticles in the body. However, these surface coatings are protective for only a short time because they are destroyed over a period of one to four hours by environmental interactions such as air exposure or ultraviolet irradiation [16,17]. To overcome this shortage, several trials have been conducted and have shown a link between long term coating of nanoparticles and a significant reduction of cytotoxicity [18].
Some say that toxicological data for nanoparticles is lacking because of the short history of nanotechnology in healthcare. However, others insist that nanomaterials are safe for healthcare use [19,20]. To settle the debate, it is necessary to clarify the physicochemical properties of nanoparticles related to toxicity. In principle, nanomaterials distinguishable characteristics are mainly assumed to originate from either their surface area or mass quantity, and their lifespan is based on biological cellular interactions. Some of them are unstable at the surface, showing unusual communication with their biological neighbors. Many recent studies have shown that this instability could be minimized by modulating some physicochemical properties. In this short review, recent trends regarding the role of nanomaterials’ physicochemical properties, in terms of in vitro and in vivo toxicological results, will be discussed (Figure 2).
Nanomaterials 05 01351 g002 1024
Figure 2. Schematic drawing of nanoparticle induced cytotoxicity. Intrinsic features of nanoparticles, such as size, surface charge, agglomeration, can significantly affect cytotoxicity. Such cytotoxicity can be affected at the levels of the cell, organ and even in vivo systems.
Figure 2. Schematic drawing of nanoparticle induced cytotoxicity. Intrinsic features of nanoparticles, such as size, surface charge, agglomeration, can significantly affect cytotoxicity. Such cytotoxicity can be affected at the levels of the cell, organ and even in vivo systems.
Nanomaterials 05 01351 g002

2. Size

Cytotoxicity is induced by nanomaterials results from the interaction between the nanomaterial surface and cellular components. As the diameter decreases, the surface area of the particle increases exponentially. Thus, even when particles have the same composition, they can have significantly different levels of cytotoxicity depending on both particle size and surface reactivity. Additionally, particle size induces significant differences in the cellular delivery mechanism and distribution in vivo. In this regard, not only are chemical properties and size-dependent cytotoxicity important in assessing a nanomaterial’s cytotoxicity, but also is the amount of size-dependent cytotoxicity.

2.1. Size-Dependent Absorption

To generate cytotoxicity and inflammatory response in animal models, it is essential that the nanoparticles should migrate across the epithelial barrier. In this respect, the size of the nanoparticles plays a key role in cytotoxicity [21,22]. In the case of nanoparticle inhalation, nanoparticles penetrate deeply into the lung parenchyma. Different sized nanoparticles show specific distribution patterns in the respiratory tract. Nanoparticle distribution is also affected by the Stokes number and Reynolds number. Initially, particles are well distributed in the gas phase, but after inhalation they translocate into the liquid phase in respiratory fluids [23,24].
Recently, Braakhuis et al. assessed cytotoxicity induced by inhaled silver nanoparticles of different size [25]. They prepared 18, 34, 60, and 160 nm silver nanoparticles and exposed rats to different concentrations of the particles. After exposure, the rats were sacrificed and the amount of silver nanoparticles in their lungs was measured. They found that silver nanoparticles in sizes of 18 and 34 nm induced lactate dehydrogenase (LDH) expression, which is a marker of cell damage, in a dose-dependent manner after 24 h. Meanwhile, there was no dose-dependent cell damage when 60 and 160 nm nanoparticles were used. Although there were more 60 and 160 nm nanoparticles measured in the lungs overall, more of the 18 and 34 nm nanoparticles were found in the alveoli. The authors indicated that the increased surface area of the nano-scaled particles was the most likely factor contributing to the toxicology of the silver nanoparticles.

2.2. Size-Dependent in Vivo Pharmacokinetics and Clearance

The distribution of a drug or nanoparticles in vivo, or pharmacokinetics, is also an important consideration in assessing cytotoxicity. Many studies have examined the in vivo distribution of nanomaterials [26]. Nanoparticles with a diameter greater than 6 nm cannot be excreted by the kidneys and accumulate in specific organs, such as the liver and spleen, until clearance by the mononuclear phagocyte system ensues [27]. Most nanoparticles that accumulate the in liver and spleen cause serious side effects. For instance, cadmium selenide (CdSe) quantum dots remain in the tissue for up to eight months and cause hepatotoxicity [28]. This pharmacokinetic characteristic of nanoparticles is dependent on particle size and surface chemistry.
The in vivo distribution of gold nanoparticles according to size was evaluated by De Jong et al. [29]. They used particles from 10 to 250 nm in size and assessed in vivo distribution after intravenous injection in a rat model. They found that 10 nm nanoparticles were distributed differently than their larger counterparts. They were found in almost all organs, including the blood, liver, spleen, kidneys, testes, thymus, heart, lungs and brain. Meanwhile, most nanoparticles larger than 50 nm were detected only in the blood, liver and spleen. The distribution of nanoparticle in several organs is shown in Figure 3. This figure is reproduced from the work of De Jong et al. [29].
Nanomaterials 05 01351 g003 1024
Figure 3. Gold nanoparticle distribution in several organs in rat according to particle size (nm).
Figure 3. Gold nanoparticle distribution in several organs in rat according to particle size (nm).
Nanomaterials 05 01351 g003

2.3. Size-Dependent Cellular Uptake and Cytotoxicity

In terms of cellular interaction, nanoparticle uptake mechanism and efficiency are key factors influencing cytotoxicity. One of the major factors determining cellular uptake efficiency and mechanism is nanoparticle size. With respect to particle size and surface features, nanoparticles are internalized into the cell through various pathways, such as phagocytosis and pinocytosis. Several internalization pathways depend on size as noted in Table 2 [30,31]. Sizes suitable for uptake range from 10 to 500 nm with an upper limit of 5 mm. Large particles are most likely to be engulfed via macropinocytosis. The size of a vesicle involved in clathrin-mediated endocytosis is about 100 nm, while the size involved in caveolae-mediated endocytosis is usually about 60–80 nm. However, the examples in the literature also cite the uptake of particles larger than those size ranges.
Table
Table 2. Examples of cellular internalization pathways of nanoparticles.
Table 2. Examples of cellular internalization pathways of nanoparticles.
Internalization pathwayMaterials of particleParticle diameter (nm)Ref.
Clathrin-mediated endocytosis [C60(C(COOH)2)2]n125[32]
PVA coated silver NP80[33]
PEGylated NP90[34]
LDH NP50–200[35]
QD4[36]
Polystyrene NP100[37]
Pristine PS NP50–200[38]
Silica NP110[39]
Herceptin–collidal gold NP2–100[40]
Silica coated iron oxide NP20[41]
AuNR [42]
bombesin peptide conjugated AuNC [43]
Caveolae-dependent endocytosis Derivatized fullerenes Baa-Lys(FITC)-(Lys) 8-OH4[44]
Perfl uorocarbon NP200[45]
Polysiloxane NP100[46]
fWGA–PLGA NP250[47]
Albumin-coated NP20–100[48]
AuNR56 × 13[49]
Pinocytosis/MacropinocytosisPVP-coated silver NP80[33]
Positively charged fluorescent polystyrene NP113[50]
Tat peptide-conjugated QD [51]
Silica NR [52]
Silver NP25[53]
IL-13 peptide conjugated PEG-PCL NP25–100[54]
Gold nanoparticles typically form a surface coated with serum proteins when incubated with cells. Serum-layered gold nanoparticles usually induce receptor-mediated endocytosis, which is dependent on particle size. The uptake efficiency of gold nanoparticles as a function of size was evaluated by Chan et al. [55]. Gold nanoparticles ranging from 1 to 100 nm were incubated with Hela cells, and the 50 nm nanoparticle showed maximal uptake efficiency by receptor-mediated endocytosis [55]. A similar experiment using ligand-coated gold nanoparticles showed that a diameter of 40–50 nm was the critical cutoff point for receptor-mediated nanoparticle internalization [40]. This phenomenon is tightly related to the nanoparticle’s binding and its cellular surface receptors. Extremely small nanoparticles have a surface curvature too great to provide necessary conformational rigidity to allow for multivalent binding with receptors. In contrast, larger nanoparticles cannot compensate for the depletion of receptors within the binding area through global diffusive motion of distant receptors, and this could limit the process of membrane wrapping that is necessary for nanoparticle internalization. As such, nanoparticles that are 40–50 nm in diameter seem to be the optimal size for both multivalent receptor interaction and binding rigidity.
Differences in endocytosis efficiency naturally affect cellular cytotoxicity. The internalized nanoparticles generally translocate to endosomal or lysosomal vesicles for further elimination [16]. During this process, endosomal escape of internalized nanoparticles occurs, resulting in specific cytotoxicity through the production of ROS and direct mitochondrial damage.

3. Surface

In addition to size and surface charge, the particle surface itself also plays a critical role in biological toxicity.

3.1. Surface Area

Band gap alterations, decreased melting point, and higher reactivity induced by a large surface area were investigated [56,57,58] and it was found that these features had serious effects including lung inflammation, cytotoxicity and toxicity in vivo. A larger surface area may cause higher reactivity with nearby particles, resulting in possibly harmful effects when used in fillers, cosmetics, and as drug carriers [59]. It can be concluded that by decreasing the particle size, its biological activity increases substantially. Smaller particles occupy less volume, such that a larger number of particles can occupy a unit area, resulting in increased pathophysiological toxicity mechanisms, for instance oxidative stress, ROS generation, mitochondrial perturbation, etc. [60]. It has yet to be determined what features of nanoparticles cause such biological toxicity. It is presumed that the size of the nanoparticle alone may not be responsible for toxicity, but that the total number per unit volume may be important. To clearly comprehend the relationship between a nanoparticle’s surface area and its biological toxicity, a group of researchers assessed acute lung inflammation with different nanoparticle surface areas and specific reactivity [61]. There were no significant differences in toxicity differences based on size; however, the total surface area played a critical role in lung inflammation. It has been clearly confirmed that pulmonary toxicity, assessed after treatment with several particles including carbon black, titanium dioxide, etc., may be induced by ultrafine and fine materials [62,63,64], which have large surface areas. Particle surface reactivity, characterized by how easily single particles aggregate, may also play a significant role in cytotoxicity [65,66,67,68]. It has also been suggested that dosing should be based on nanoparticle surface area.

3.2. Surface Electrostatic Status

Due to their small size, nanoparticles are usually used as a drug carrier via either passive or active transport. Their effective cellular internationalization depends upon biocompatibility [27,69,70]. In particular, external properties of surface electronic status are critical to cellular uptake and may also be involved in cytotoxicity. Traditionally, to study in vitro efficacy, nanocarriers are instilled into a 2D layered target cell for both therapeutic and diagnostic studies. However, such methodology should be reconsidered prior to in vivo study, because such a layered model may be dissimilar to that of a cell niche where cell to cell communications are critical for metabolic progress. Nonetheless, nanoparticles for delivery are currently designed based on ex vivo conditions mimicking tissue environments [71,72]. Similar methods are used to assess nanoparticle toxicology [73,74]. Higher uptake efficiency in a cell is achieved by replacing the surface functional moiety, inducing sudden changes in particles’ surface charge [75,76]. Some authors have attempted to envelope nanoparticles in a lipid vesicle [77].
Changes in surface charge result in considerable differences in the in vivo biodistribution of nanoparticles. Even though some nanoparticles, including polymeric nanocomplexes and gold nanospheres, have the same range of size variations, different surface charges yielded marked discrepancies in both distribution and uptake efficiency. Particles showed different degrees of toxicity depending on their surface charges [78,79,80,81]. Nanoparticles with a positively charged surface tended to have much higher toxicity.

4. Morphology

Morphology is also a big issue in nanotoxicology. Like other well-established inhalable fibers (e.g., asbestos), nanoscaled fibers (e.g., carbon nanotubes) are reported to have a serious risk of lung inflammation. Furthermore, prolonged exposure may cause several cancers [82,83,84]. It is difficult to determine whether there is a certain toxic effect of single nanotubes or an ensemble of such tubes. Some studies have shown that carbon nanotubes are more toxic than other ultra-fine carbon black or silica dusts. Most workers exposed to single-walled carbon nanotubes (SWCNTs) beyond the current permissible exposure limit (PEL) developed lung lesions [85]. Interestingly, CNTs have been shown to cause death of targeted kidney cells via inhibited cell growth induced by decreased cell adhesiveness [86]. Human exposure to fullerene (also termed Buckyball) resulted in severe lung damage [87,88] in addition to destruction of fish brain and water flea death [89,90,91,92].

5. Agglomeration Status

Irrespective of any physicochemical properties of nanoparticles, such as chemical composition, agglomeration could be a potent inducer of inflammatory lung injury in humans [93,94]. For certain types of chemicals, exposure at higher levels has been shown to lead to serious chronic diseases such as fibrosis and cancer [95]. It is still under consideration to figure out what features are inducing such toxicological effect in a living organism.

6. Summary

The ability to engineer nanometer-size materials has been proven to have great value in several fields, including basic science, such as chemistry, physics, biology and even engineering fields like biotechnology and electronics. Prior to the widespread introduction of such nanotechnology in medicine, its safety in biological systems should be investigated thoroughly. All physicochemical properties of nanoparticles should be evaluated in order to elucidate their interaction with subcellular organelles, cells, tissues, and organisms. Such investigations will provide us with strategies to engineer new generations of nontoxic products containing nanoparticles. These fundamental studies will help to generate criteria for the smart design of nanoparticle which can be used in vivo.

Acknowledgments

This work was supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant no. HI14C3301) and by Basic Science Research Programs through the National Research Foundation (NRF) funded by the Ministry of Science ICT and Future Planning (Grant Nos. 2013R1A1A1058670 and 2013R1A1A2016781) and by the International Research & Development Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (grant no. 2015K1A3A1A21000238).

Author Contributions

S.W.S. and I.H.S. designed the subject of review article and wrote the manuscript. S.W.S. and S.H.U. conceived the project, designed the subject, discussed several related articles, supervised the task, and wrote the manuscript. All authors reviewed and approved the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Maskos, M.; Stauber, R.H. 3.319 - Characterization of nanoparticles in biological environments. In Comprehensive Biomaterials; Ducheyne, P., Ed.; Elsevier: Oxford, UK, 2011; pp. 329–339. [Google Scholar]
  2. Lewinski, N.; Colvin, V.; Drezek, R. Cytotoxicity of nanoparticles. Small 2008, 4, 26–49. [Google Scholar] [CrossRef] [PubMed]
  3. Favi, P.M.; Gao, M.; Johana Sepúlveda Arango, L.; Ospina, S.P.; Morales, M.; Pavon, J.J.; Webster, T.J. Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars. J. Biomed. Mater. Res. Part A 2015. [Google Scholar] [CrossRef] [PubMed]
  4. Pan, Y.; Neuss, S.; Leifert, A.; Fischler, M.; Wen, F.; Simon, U.; Schmid, G.; Brandau, W.; Jahnen-Dechent, W. Size-dependent cytotoxicity of gold nanoparticles. Small 2007, 3, 1941–1949. [Google Scholar] [CrossRef] [PubMed]
  5. Napierska, D.; Thomassen, L.C.; Rabolli, V.; Lison, D.; Gonzalez, L.; Kirsch-Volders, M.; Martens, J.A.; Hoet, P.H. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 2009, 5, 846–853. [Google Scholar] [CrossRef] [PubMed]
  6. Carlson, C.; Hussain, S.M.; Schrand, A.M.; K. Braydich-Stolle, L.; Hess, K.L.; Jones, R.L.; Schlager, J.J. Unique cellular interaction of silver nanoparticles: Size-dependent generation of reactive oxygen species. J. Phys. Chem. B 2008, 112, 13608–13619. [Google Scholar] [CrossRef] [PubMed]
  7. Oberdörster, G.; Oberdörster, E.; Oberdörster, J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113, 823–839. [Google Scholar] [CrossRef] [PubMed]
  8. Handy, R.D.; Owen, R.; Valsami-Jones, E. The ecotoxicology of nanoparticles and nanomaterials: Current status, knowledge gaps, challenges, and future needs. Ecotoxicology 2008, 17, 315–325. [Google Scholar] [CrossRef] [PubMed]
  9. Hussain, S.; Hess, K.; Gearhart, J.; Geiss, K.; Schlager, J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. Vitr. 2005, 19, 975–983. [Google Scholar] [CrossRef] [PubMed]
  10. Brown, J.S.; Zeman, K.L.; Bennett, W.D. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am. J. Respir. Crit. Care Med. 2002, 166, 1240–1247. [Google Scholar] [CrossRef] [PubMed]
  11. Holsapple, M.P.; Farland, W.H.; Landry, T.D.; Monteiro-Riviere, N.A.; Carter, J.M.; Walker, N.J.; Thomas, K.V. Research strategies for safety evaluation of nanomaterials, part ii: Toxicological and safety evaluation of nanomaterials, current challenges and data needs. Toxicol. Sci. 2005, 88, 12–17. [Google Scholar] [CrossRef] [PubMed]
  12. Hoshino, A.; Fujioka, K.; Oku, T.; Nakamura, S.; Suga, M.; Yamaguchi, Y.; Suzuki, K.; Yasuhara, M.; Yamamoto, K. Quantum dots targeted to the assigned organelle in living cells. Microbiol. Immunol. 2004, 48, 985–994. [Google Scholar] [CrossRef] [PubMed]
  13. Salnikov, V.; Lukyanenko, Y.; Frederick, C.; Lederer, W.; Lukyanenko, V. Probing the outer mitochondrial membrane in cardiac mitochondria with nanoparticles. Biophys. J. 2007, 92, 1058–1071. [Google Scholar] [CrossRef] [PubMed]
  14. Donaldson, K.; Stone, V. Current hypotheses on the mechanisms of toxicity of ultrafine particles. Ann. Ist. Super. Sanita 2002, 39, 405–410. [Google Scholar]
  15. Wilson, R.F. Nanotechnology: The challenge of regulating known unknowns. J. Law Med. Ethics 2006, 34, 704–713. [Google Scholar] [CrossRef] [PubMed]
  16. Wichmann, H.-E.; Spix, C.; Tuch, T.; Wölke, G.; Peters, A.; Heinrich, J.; Kreyling, W.G.; Heyder, J. Daily Mortality and Fine and Ultrafine Particles in Erfurt, Germany. Part I: Role Of Particle Number And Particle Mass; Research Report 98; Health Effects Institute: Boston, MA, USA, 2000. [Google Scholar]
  17. Derfus, A.M.; Chan, W.C.; Bhatia, S.N. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett. 2004, 4, 11–18. [Google Scholar] [CrossRef]
  18. Gupta, A.K.; Gupta, M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26, 3995–4021. [Google Scholar] [CrossRef] [PubMed]
  19. De Jong, W.H.; Borm, P.J. Drug delivery and nanoparticles: Applications and hazards. Int. J. Nanomed. 2008, 3, 133. [Google Scholar] [CrossRef]
  20. Alkilany, A.M.; Murphy, C.J. Toxicity and cellular uptake of gold nanoparticles: What we have learned so far? J. Nanoparticle Res. 2010, 12, 2313–2333. [Google Scholar] [CrossRef] [PubMed]
  21. Lefebvre, D.E.; Venema, K.; Gombau, L.; Valerio Jr, L.G.; Raju, J.; Bondy, G.S.; Bouwmeester, H.; Singh, R.P.; Clippinger, A.J.; Collnot, E.-M. Utility of models of the gastrointestinal tract for assessment of the digestion and absorption of engineered nanomaterials released from food matrices. Nanotoxicology 2015, 9, 523–542. [Google Scholar] [CrossRef] [PubMed]
  22. Bellmann, S.; Carlander, D.; Fasano, A.; Momcilovic, D.; Scimeca, J.A.; Waldman, W.J.; Gombau, L.; Tsytsikova, L.; Canady, R.; Pereira, D.I. Mammalian gastrointestinal tract parameters modulating the integrity, surface properties, and absorption of food-relevant nanomaterials. WIREs Nanomed. Nanobiotechnol. 2015, 7, 609–622. [Google Scholar] [CrossRef] [PubMed]
  23. Gliga, A.R.; Skoglund, S.; Wallinder, I.O.; Fadeel, B.; Karlsson, H.L. Size-dependent cytotoxicity of silver nanoparticles in human lung cells: The role of cellular uptake, agglomeration and ag release. Part. Fibre Toxicol. 2014, 11, 11. [Google Scholar] [CrossRef] [PubMed]
  24. Qiao, H.; Liu, W.; Gu, H.; Wang, D.; Wang, Y. The transport and deposition of nanoparticles in respiratory system by inhalation. J. Nanomater. 2015, 2015, 394507. [Google Scholar] [CrossRef]
  25. Braakhuis, H.M.; Cassee, F.R.; Fokkens, P.H.; de la Fonteyne, L.J.; Oomen, A.G.; Krystek, P.; de Jong, W.H.; van Loveren, H.; Park, M.V. Identification of the appropriate dose metric for pulmonary inflammation of silver nanoparticles in an inhalation toxicity study. Nanotoxicology 2015. [Google Scholar] [CrossRef] [PubMed]
  26. Varna, M.; Ratajczak, P.; Ferreira, I.; Leboeuf, C.; Bousquet, G.; Janin, A. In vivo distribution of inorganic nanoparticles in preclinical models. J. Biomater. Nanobiotechnol. 2012, 3, 18986. [Google Scholar] [CrossRef]
  27. Albanese, A.; Tang, P.S.; Chan, W.C. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng. 2012, 14, 1–16. [Google Scholar] [CrossRef] [PubMed]
  28. Ballou, B.; Lagerholm, B.C.; Ernst, L.A.; Bruchez, M.P.; Waggoner, A.S. Noninvasive imaging of quantum dots in mice. Bioconjug. Chem. 2004, 15, 79–86. [Google Scholar] [CrossRef] [PubMed]
  29. De Jong, W.H.; Hagens, W.I.; Krystek, P.; Burger, M.C.; Sips, A.J.; Geertsma, R.E. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008, 29, 1912–1919. [Google Scholar] [CrossRef] [PubMed]
  30. Zhao, F.; Zhao, Y.; Liu, Y.; Chang, X.; Chen, C.; Zhao, Y. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small 2011, 7, 1322–1337. [Google Scholar] [CrossRef] [PubMed]
  31. Kou, L.; Sun, J.; Zhai, Y.; He, Z. The endocytosis and intracellular fate of nanomedicines: Implication for rational design. Asian J. Pharm. Sci. 2013, 8, 1–10. [Google Scholar] [CrossRef]
  32. Li, W.; Chen, C.; Ye, C.; Wei, T.; Zhao, Y.; Lao, F.; Chen, Z.; Meng, H.; Gao, Y.; Yuan, H. The translocation of fullerenic nanoparticles into lysosome via the pathway of clathrin-mediated endocytosis. Nanotechnology 2008, 19, 145102. [Google Scholar] [CrossRef] [PubMed]
  33. Greulich, C.; Diendorf, J.; Simon, T.; Eggeler, G.; Epple, M.; Köller, M. Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater. 2011, 7, 347–354. [Google Scholar] [CrossRef] [PubMed]
  34. Harush-Frenkel, O.; Debotton, N.; Benita, S.; Altschuler, Y. Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochem. Biophys. Res. Commun. 2007, 353, 26–32. [Google Scholar] [CrossRef] [PubMed]
  35. Oh, J.M.; Choi, S.J.; Lee, G.E.; Kim, J.E.; Choy, J.H. Inorganic metal hydroxide nanoparticles for targeted cellular uptake through clathrin-mediated endocytosis. Chem. Asian J. 2009, 4, 67–73. [Google Scholar] [CrossRef] [PubMed]
  36. Jiang, X.; Röcker, C.; Hafner, M.; Brandholt, S.; Dörlich, R.M.; Nienhaus, G.U. Endo-and exocytosis of zwitterionic quantum dot nanoparticles by live hela cells. ACS Nano 2010, 4, 6787–6797. [Google Scholar] [CrossRef] [PubMed]
  37. Jiang, X.; Dausend, J.; Hafner, M.; Musyanovych, A.; Röcker, C.; Landfester, K.; Mailänder, V.; Nienhaus, G.U. Specific effects of surface amines on polystyrene nanoparticles in their interactions with mesenchymal stem cells. Biomacromolecules 2010, 11, 748–753. [Google Scholar] [CrossRef] [PubMed]
  38. Kam, N.W.S.; Liu, Z.; Dai, H. Carbon nanotubes as intracellular transporters for proteins and DNA: An investigation of the uptake mechanism and pathway. Angew. Chem. 2006, 118, 591–595. [Google Scholar] [CrossRef]
  39. Huang, D.-M.; Hung, Y.; Ko, B.-S.; Hsu, S.-C.; Chen, W.-H.; Chien, C.-L.; Tsai, C.-P.; Kuo, C.-T.; Kang, J.-C.; Yang, C.-S. Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: Implication for stem cell tracking. FASEB J. 2005, 19, 2014–2016. [Google Scholar] [CrossRef] [PubMed]
  40. Jiang, W.; Kim, B.Y.; Rutka, J.T.; Chan, W.C. Nanoparticle-mediated cellular response is size-dependent. Nat. Nanotechnol. 2008, 3, 145–150. [Google Scholar] [CrossRef] [PubMed]
  41. Bohmer, N.; Jordan, A. Caveolin-1 and CDC42 mediated endocytosis of silica-coated iron oxide nanoparticles in hela cells. Beilstein J. Nanotechnol. 2015, 6, 167–176. [Google Scholar] [CrossRef] [PubMed]
  42. Klingberg, H.; Oddershede, L.B.; Loeschner, K.; Larsen, E.H.; Loft, S.; Møller, P. Uptake of gold nanoparticles in primary human endothelial cells. Toxicol. Res. 2015, 655–666. [Google Scholar] [CrossRef]
  43. Suresh, D.; Zambre, A.; Chanda, N.; Hoffman, T.J.; Smith, C.J.; Robertson, J.D.; Kannan, R. Bombesin peptide conjugated gold nanocages internalize via clathrin mediated endocytosis. Bioconjug. Chem. 2014, 25, 1565–1579. [Google Scholar] [CrossRef] [PubMed]
  44. Zhang, L.W.; Yang, J.; Barron, A.R.; Monteiro-Riviere, N.A. Endocytic mechanisms and toxicity of a functionalized fullerene in human cells. Toxicol. Lett. 2009, 191, 149–157. [Google Scholar] [CrossRef] [PubMed]
  45. Partlow, K.C.; Lanza, G.M.; Wickline, S.A. Exploiting lipid raft transport with membrane targeted nanoparticles: A strategy for cytosolic drug delivery. Biomaterials 2008, 29, 3367–3375. [Google Scholar] [CrossRef] [PubMed]
  46. Nishikawa, T.; Iwakiri, N.; Kaneko, Y.; Taguchi, A.; Fukushima, K.; Mori, H.; Morone, N.; Kadokawa, J.-i. Nitric oxide release in human aortic endothelial cells mediated by delivery of amphiphilic polysiloxane nanoparticles to caveolae. Biomacromolecules 2009, 10, 2074–2085. [Google Scholar] [CrossRef] [PubMed]
  47. Mo, Y.; Lim, L.Y. Mechanistic study of the uptake of wheat germ agglutinin-conjugated plga nanoparticles by A549 cells. J. Pharm. Sci. 2004, 93, 20–28. [Google Scholar] [CrossRef] [PubMed]
  48. Wang, Z.; Tiruppathi, C.; Minshall, R.D.; Malik, A.B. Size and dynamics of caveolae studied using nanoparticles in living endothelial cells. ACS Nano 2009, 3, 4110–4116. [Google Scholar] [CrossRef] [PubMed]
  49. Wang, L.; Liu, Y.; Li, W.; Jiang, X.; Ji, Y.; Wu, X.; Xu, L.; Qiu, Y.; Zhao, K.; Wei, T. Selective targeting of gold nanorods at the mitochondria of cancer cells: Implications for cancer therapy. Nano Lett. 2010, 11, 772–780. [Google Scholar] [CrossRef] [PubMed]
  50. Dausend, J.; Musyanovych, A.; Dass, M.; Walther, P.; Schrezenmeier, H.; Landfester, K.; Mailänder, V. Uptake mechanism of oppositely charged fluorescent nanoparticles in hela cells. Macromol. Biosci. 2008, 8, 1135–1143. [Google Scholar] [CrossRef] [PubMed]
  51. Ruan, G.; Agrawal, A.; Marcus, A.I.; Nie, S. Imaging and tracking of tat peptide-conjugated quantum dots in living cells: New insights into nanoparticle uptake, intracellular transport, and vesicle shedding. J. Am. Chem. Soc. 2007, 129, 14759–14766. [Google Scholar] [CrossRef] [PubMed]
  52. Meng, H.; Yang, S.; Li, Z.; Xia, T.; Chen, J.; Ji, Z.; Zhang, H.; Wang, X.; Lin, S.; Huang, C. Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small gtpase-dependent macropinocytosis mechanism. ACS Nano 2011, 5, 4434–4447. [Google Scholar] [CrossRef] [PubMed]
  53. Trefry, J.C.; Wooley, D.P. Silver nanoparticles inhibit vaccinia virus infection by preventing viral entry through a macropinocytosis-dependent mechanism. J. Biomed. Nanotechnol. 2013, 9, 1624–1635. [Google Scholar] [CrossRef] [PubMed]
  54. Gao, H.; Yang, Z.; Zhang, S.; Cao, S.; Shen, S.; Pang, Z.; Jiang, X. Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization. Sci. Rep. 2013, 3, 2543. [Google Scholar] [CrossRef] [PubMed]
  55. Chithrani, B.D.; Ghazani, A.A.; Chan, W.C. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006, 6, 662–668. [Google Scholar] [CrossRef] [PubMed]
  56. Klabunde, K.J.; Stark, J.; Koper, O.; Mohs, C.; Park, D.G.; Decker, S.; Jiang, Y.; Lagadic, I.; Zhang, D. Nanocrystals as stoichiometric reagents with unique surface chemistry. J. Phys. Chem. 1996, 100, 12142–12153. [Google Scholar] [CrossRef]
  57. Campbell, C.T.; Parker, S.C.; Starr, D.E. The effect of size-dependent nanoparticle energetics on catalyst sintering. Science 2002, 298, 811–814. [Google Scholar] [CrossRef] [PubMed]
  58. Suttiponparnit, K.; Jiang, J.; Sahu, M.; Suvachittanont, S.; Charinpanitkul, T.; Biswas, P. Role of surface area, primary particle size, and crystal phase on titanium dioxide nanoparticle dispersion properties. Nanoscale Res. Lett. 2011, 6, 27. [Google Scholar] [CrossRef]
  59. Nel, A.; Xia, T.; Madler, L.; Li, N. Toxic potential of materials ar the nanolevel. Science 2006, 311, 622–627. [Google Scholar] [CrossRef] [PubMed]
  60. Oberdorster, G.; Maynard, A.; Donaldson, K.; Castranova, V.; Fitzpatrick, J.; Ausman, K.; Carter, J.; Karn, B.; Kreyling, W.; Lai, D.; et al. Principles for characterizing the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Part. Fibre Toxicol. 2005, 2, 8–43. [Google Scholar] [CrossRef] [PubMed]
  61. Duffine, R.; Tran, C.L.; Clouter, A.; Brown, D.M.; MacNee, W.; Stone, V.; Donaldson, K. The importance of surface area and specific reactivity in the acute pulmonary inflammatory respones to particles. Ann. Occup. Hyg. 2002, 46, 242–245. [Google Scholar] [CrossRef]
  62. Stoeger, T.; Reinhard, C.; Takenaka, S.; Schroeppel, A.; Karg, E.; Ritter, B.; Heyder, J.; Schulz, H. Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice. Environm. Health Perspect. 2005, 114, 328–333. [Google Scholar] [CrossRef]
  63. Sager, T.M.; Kommineni, C.; Castranova, V. Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: Role of particle surface area. Part. Fibre Toxicol. 2008, 5, 17–32. [Google Scholar] [CrossRef] [PubMed]
  64. Sager, T.M.; Castranova, V. Surface area of particle administered versus mass in determining the pulmonary toxicity of ultrafine and fine carbon black: Comparison to ultrafine titanium dioxide. Part. Fibre Toxicol. 2009, 6, 15–46. [Google Scholar] [CrossRef] [PubMed]
  65. Warheit, D.B.; Reed, K.L.; Sayes, C.M. A role for nanoparticle surface reactivity in facilitating pulmonary toxicity and development of a base set of hazard assays as a component of nanoparticle risk management. Inhal. Toxicol. 2009, 21, 61–67. [Google Scholar] [CrossRef] [PubMed]
  66. Monteiller, C.; Tran, L.; MacNee, W.; Faux, S.; Jones, A.; Miller, B.; Donaldson, K. The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: The role of surface area. Occup. Environ. Med. 2007, 64, 609–615. [Google Scholar] [CrossRef] [PubMed]
  67. Rabolli, V.; Thomassen, L.C.; Uwambayinema, F.; Martens, J.A.; Lison, D. The cytotoxic activity of amorphous silica nanoparticles is mainly influenced by surface area and not by aggregation. Toxicol. Lett. 2011, 206, 197–203. [Google Scholar] [CrossRef] [PubMed]
  68. Lin, W.; Huang, Y.W.; Zhou, X.D.; Ma, Y. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol. Appl. Pharm. 2006, 217, 252–259. [Google Scholar] [CrossRef] [PubMed]
  69. Wang, A.Z.; Langer, R.; Farokhzad, O.C. Nanoparticle delivery of cancer drugs. Annu. Rev. Med. 2012, 63, 185–198. [Google Scholar] [CrossRef] [PubMed]
  70. Verma, A.; Stellacci, F. Effect of surface properties on nanoparticle-cell interactions. Small 2010, 6, 12–21. [Google Scholar] [CrossRef] [PubMed]
  71. Albanese, A.; Lam, A.K.; Sykes, E.A.; Rocheleau, J.V.; Chan, W.C. Tumour-on-a-chip provides an optical window into nanoparticle tissue transport. Nat. Commun. 2013, 4, 2718. [Google Scholar] [CrossRef] [PubMed]
  72. Valencia, P.M.; Farokhzad, O.C.; Karnik, R.; Langer, R. Microfluidic technologies for accelerating the clinical translation of nanoparticles. Nat. Nanotechnol. 2012, 7, 623–629. [Google Scholar] [CrossRef] [PubMed]
  73. Esch, M.B.; King, T.L.; Shuler, M.L. The role of body-on-a-chip devices in drug and toxicity studies. Annu. Rev. Biomed. Eng. 2011, 13, 55–72. [Google Scholar] [CrossRef] [PubMed]
  74. Toh, Y.C.; Lim, T.C.; Tai, D.; Xiao, G.; van Noort, D.; Yu, H. A microfluidic 3D hepatocyte chip for drug toxicity testing. Lab Chip 2009, 9, 2026–2035. [Google Scholar] [CrossRef] [PubMed]
  75. He, C.; Hu, Y.; Yin, L.; Tang, C.; Yin, C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 2010, 31, 3657–3666. [Google Scholar] [CrossRef] [PubMed]
  76. Hirn, S.; Semmler-Behnke, M.; Schleh, C.; Wenk, A.; Lipka, J.; Schaffler, M.; Takenaka, S.; Moller, W.; Schmid, G.; Simon, U.; et al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur. J. Pharm. Biopharm. 2011, 77, 407–416. [Google Scholar] [CrossRef] [PubMed]
  77. Malam, Y.; Loizidou, M.; Seifalian, A.M. Liposomes and nanoparticles: Nanosized vehicles for drug delivery in cancer. Trends Pharm. Sci. 2009, 30, 592–599. [Google Scholar] [CrossRef] [PubMed]
  78. Jiang, J.; Oberdörster, G.; Biswas, P. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J. Nanopart. Res. 2008, 11, 77–89. [Google Scholar] [CrossRef]
  79. Asati, A.; Santra, S.; Kaittanis, C.; Perez, J.M. Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. ACS Nano 2010, 4, 5321–5331. [Google Scholar] [CrossRef] [PubMed]
  80. Frohlich, E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int. J. Nanomed. 2012, 7, 5577–5591. [Google Scholar] [CrossRef] [PubMed]
  81. Schaeublin, N.M.; Braydich-Stolle, L.K.; Schrand, A.M.; Miller, J.M.; Hutchison, J.; Schlager, J.J.; Hussain, S.M. Surface charge of gold nanoparticles mediates mechanism of toxicity. Nanoscale 2011, 3, 410–420. [Google Scholar] [CrossRef] [PubMed]
  82. Cha, K.E.; Myung, H. Cytotoxic effects of nanoparticles assessed in vitro and in vivo. J. Microbiol. Biotechnol. 2007, 17, 1573–1578. [Google Scholar] [PubMed]
  83. Huczko, A.; Lange, H.; Całko, E.; Grubek-Jaworska, H.; Droszcz, P. Physiological testing of carbon nanotubes: Are they asbestos-like? Fuller. Sci. Technol. 2001, 9, 251–254. [Google Scholar] [CrossRef]
  84. Firme, C.P.; Bandaru, P.R. Toxicity issues in the application of carbon nanotubes to biological systems. Nanomed. Nanotechnol. Biol. Med. 2010, 6, 245–256. [Google Scholar] [CrossRef] [PubMed]
  85. Chalupa, D.C.; Morrow, P.E.; Oberdörster, G.; Utell, M.J.; Frampton, M.W. Ultrafine particle deposition in subjects with asthma. Environ. Health Perspect. 2004, 112, 879–882. [Google Scholar] [CrossRef] [PubMed]
  86. Handy, R.D.; Henry, T.B.; Scown, T.M.; Johnston, B.D.; Tyler, C.R. Manufactured nanoparticles: Their uptake and effects on fish—A mechanistic analysis. Ecotoxicology 2008, 17, 396–409. [Google Scholar] [CrossRef] [PubMed]
  87. Baker, G.L.; Gupta, A.; Clark, M.L.; Valenzuela, B.R.; Staska, L.M.; Harbo, S.J.; Pierce, J.T.; Dill, J.A. Inhalation toxicity and lung toxicokinetics of C60 fullerene nanoparticles and microparticles. Toxicol. Sci. 2008, 101, 122–131. [Google Scholar] [CrossRef] [PubMed]
  88. Elder, A.C.P.; Gelein, R.; Finkelstein, J.N.; Cox, C.; Oberdorster, G. Pulmonary inflammatory response to inhaled ultrafine particles is modified by age, ozone exposure, and bacterial toxin. Inhal. Toxicol. 2000, 12, 227–246. [Google Scholar] [PubMed]
  89. Oberdörster, E. Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environ. Health Perspect. 2004, 112, 1058–1062. [Google Scholar] [CrossRef] [PubMed]
  90. Lovern, S.B.; Klaper, R. Daphnia magna mortality when exposed to titanium dioxide and fullerene (C60) nanoparticles. Environ. Toxicol. Chem. 2006, 25, 1132–1137. [Google Scholar] [CrossRef] [PubMed]
  91. Lyon, D.Y.; Adams, L.K.; Falkner, J.C.; Alvarez, P.J.J. Antibacterial activity of fullerene water suspensions: Effects of preparation method and particle size. Environ. Sci. Technol. 2006, 40, 4360–4366. [Google Scholar] [CrossRef] [PubMed]
  92. Lyon, D.Y.; Fortner, J.D.; Sayes, C.M.; Colvin, V.L.; Hughes, J.B. Bacterial cell association and antimicrobial activity of a c60 water suspension. Environ. Toxicol. Chem. 2005, 24, 2757–2762. [Google Scholar] [CrossRef] [PubMed]
  93. Li, Z.; Hulderman, T.; Salmen, R.; Chapman, R.; Leonard, S.S.; Young, S.H.; Shvedova, A.; Luster, M.I.; Simeonova, P.P. Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes. Environ. Health Perspect. 2007, 115, 377–382. [Google Scholar] [CrossRef] [PubMed]
  94. Bantz, C.; Koshkina, O.; Lang, T.; Galla, H.-J.; Kirkpatrick, C.J.; Stauber, R.H.; Maskos, M. The surface properties of nanoparticles determine the agglomeration state and the size of the particles under physiological conditions. Beilstein J. Nanotechnol. 2014, 5, 1774–1786. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  95. Donaldson, K.; Aitken, R.; Tran, L.; Stone, V.; Duffin, R.; Forrest, G.; Alexander, A. Carbon nanotubes: A review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol. Sci. 2006, 92, 5–22. [Google Scholar]

Share and Cite

MDPI and ACS Style

Shin, S.W.; Song, I.H.; Um, S.H. Role of Physicochemical Properties in Nanoparticle Toxicity. Nanomaterials 2015, 5, 1351-1365. https://doi.org/10.3390/nano5031351

AMA Style

Shin SW, Song IH, Um SH. Role of Physicochemical Properties in Nanoparticle Toxicity. Nanomaterials. 2015; 5(3):1351-1365. https://doi.org/10.3390/nano5031351

Chicago/Turabian Style

Shin, Seung Won, In Hyun Song, and Soong Ho Um. 2015. "Role of Physicochemical Properties in Nanoparticle Toxicity" Nanomaterials 5, no. 3: 1351-1365. https://doi.org/10.3390/nano5031351

Article Metrics

Back to TopTop